现在位置 >首页 > 时讯速递
[JAMA Surg发表论文]:术后并发症和病死率的预测模型已关闭评论
Original Investigation  MySurgeryRisk Model Predictions of Postoperative Complications and Mortality Yuanfang Ren, Esra Adiyeke, Ziyuan Guan, et al JAMA Surg Published Online: April 29, 2026 doi: 10.1001/jamasurg.2026.1112 Key Points Question  Will applying the MySurgeryRisk framework, originally developed and prospectively validated on a single-center dataset, to a large multicenter dataset enh...
阅读全文
[JAMA Netw Open发表论文]:夜间院外心跳骤停的生存率已关闭评论
Original Investigation  Emergency Medicine Out-of-Hospital Cardiac Arrest Survival at Nighttime: A Nationwide Cohort Study Joshua M. Kimbrell, Tanner Smida, Judah A. Kreinbrook, et al JAMA Netw Open 2026;9;(4):e269828. doi:10.1001/jamanetworkopen.2026.9828 Key Points Question  Does out-of-hospital cardiac arrest resuscitation with nighttime prehospital response remain associated with low rates of survival u...
阅读全文
[NEJM发表论文]:美国医院的医疗相关感染:2023 vs 2015已关闭评论
ORIGINAL ARTICLE Health Care–Associated Infections in U.S. Hospitals, 2023 versus 2015 Nora Chea, Rongxia Li, Taniece Eure, et al N Engl J Med 2026;395:255-266 DOI: 10.1056/NEJMoa2510881 Abstract BACKGROUND Prevalence surveys in U.S. hospitals showed that on any given day, 1 of 25 patients had a health care–associated infection in 2011, as compared with 1 of 31 patients in 2015. We repeated the survey in 2023 to assess changes in the prevalence of suc...
阅读全文
[Lancet Respir Med发表论文]:床旁鉴别急性呼吸功能衰竭的亚表型已关闭评论
Articles Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study Kiran Reddy, Pratik Sinha, David B Antcliffe, et al Lancent Respir Med Available online 23 March 2026 https://doi.org/10.1016/S2213-2600(26)00040-8 Summary Background Acute respiratory distress syndrome (ARDS) is a clinically defined, biologically heterogeneous condition with no proven disease-modifying therapies. Retrospect...
阅读全文
[Lancet Respir Med发表论文]:多粘菌素B血液吸附治疗内毒素性感染性休克已关闭评论
Articles Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial Javier A Neyra, Matthieu Legrand, Mark A Tidswell, et al Lancet Respir Med Available online 23 March 2026 https://doi.org/10.1016/S2213-2600(26)00047-0 Summary Background Endotoxic septic shock, a subset of septic shock with high endotoxin activity and multiorgan failure, is associated with high risk of de...
阅读全文
[Lancet Microbe发表论文]:通过血浆游离DNA宏基因组测序预测血流感染已关闭评论
Articles Predicting bloodstream infection by plasma cell-free metagenomic sequencing: a prospective cohort study Joshua Wolf, Kathryn P Goggin, Yuki Inaba, et al Lancet Microbe 2026; 7: 101312 https://doi.org/10.1016/j.lanmic.2025.101312 Summary Background Patients receiving myelosuppressive chemotherapy or haematopoietic cell transplantation are at high risk for life-threatening bloodstream infections. A novel pre-emptive treatment paradigm guided by...
阅读全文
[Lancet Microbe发表论文]:法国肝移植受体的侵袭性曲霉菌病已关闭评论
Articles Invasive aspergillosis in liver transplant recipients in France (2007–21): a nationwide, retrospective, matched case–control study Coralie Le Hyaric, Cléa Melenotte, François Lefebvre, et al Lancet Microbe 2026; 7: 101272 https://doi.org/10.1016/j.lanmic.2025.101272  Summary Background Invasive aspergillosis is a rare but severe complication of liver transplantation. Incidence varies from 1·2% to 5·6% and mortality is greater than 50%. Few st...
阅读全文
[NEJM发表论文]:高危门诊患者口服奈玛特韦-利托那韦治疗新冠肺炎已关闭评论
ORIGINAL ARTICLE Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients Christopher C. Butler, Andrew D. Pinto, Victoria Harris, et al N Engl J Med 2026;394:1583-1594 DOI: 10.1056/NEJMoa2502457 Abstract BACKGROUND Nirmatrelvir–ritonavir has been shown to reduce progression to severe illness from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in unvaccinated high-risk outpatients. The effectiveness of nirmatrelvir–ritonavir i...
阅读全文
[JAMA发表论文]:肺局限性顽固性IV期非小细胞肺癌的肺移植已关闭评论
Original Investigation  Lung Transplant for Refractory Lung-Limited Stage IV Non–Small Cell Lung Cancer Ankit Bharat, Chitaru Kurihara, Liam IL-Young Chung, et al JAMA Published Online: July 8, 2026 doi: 10.1001/jama.2026.8717 Key Points Question  Among selected adults with medically refractory, lung-limited, stage IV non–small cell lung cancer (NSCLC), what are the outcomes with lung transplant and how does early overall survival compare ...
阅读全文
[JAMA Netw Open发表论文]:达巴万星治疗复杂性金黄色葡萄球菌菌血症的药代动力学已关闭评论
Original Investigation  Infectious Diseases Pharmacokinetics of Dalbavancin in Complicated Staphylococcus aureus Bacteremia: A Secondary Analysis of the DOTS Randomized Clinical Trial Thomas P. Lodise, Nicholas A. Turner, Toshimitsu Hamasaki, et al JAMA Netw Open 2026;9;(4):e2611652. doi:10.1001/jamanetworkopen.2026.11652 Key Points Question  What are the pharmacokinetics of a 2-dose dalbavancin regimen used for consolidation therapy in co...
阅读全文
×
腾讯微博